Omvik, Per
Karolinska University Hospital · Cornell University · University of Michigan · Helsinki University Hospital · Sahlgrenska University Hospital · Aarhus University Hospital · Umeå University
4 papers on CoChat
Most cited papers
- Verified
Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet
Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies
Cited by 5,407
- Verified
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., et al. (2002) · The Lancet
Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Cited by 1,560
- Verified · note
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
Ibsen, H., Olsen, M. H., Wachtell, K., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlöf, B., Devereux, R. B., de Faire, U., Fyhrquist, F., et al. (2005) · Hypertension
Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes
Cited by 562
- Verified
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study
Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Olsen, M. H., Wachtell, K., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., et al. (2002) · Journal of Hypertension
Blood Pressure and Hypertension StudiesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 392
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free